Mapp Biopharmaceutical

About:

Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases.

Website: http://mappbio.com/

Top Investors: U.S. Department of Health & Human Services

Description:

Mapp Biopharmaceutical was created to develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense. The company has been developing an Ebola therapy for more than a decade and has been working with the United States and Canadian governments to develop this therapy. Mapp Biopharmaceutical was founded in 2003 by Kevin Whaley and Larry Zeitlin. It is headquartered in San Diego, C.A.